Definium Therapeutics, Inc. (DFTX)
22.72
-0.70
(-2.99%)
USD |
NASDAQ |
May 07, 12:58
Definium Therapeutics SG&A Expense (TTM) : 48.64M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Atai Beckley, Inc. | 65.09M |
| Plus Therapeutics, Inc. | 12.13M |
| Viridian Therapeutics, Inc. | 78.21M |
| Nutriband, Inc. | 6.993M |
| Immunovant, Inc. | 79.15M |